The new series ACS Headline Science kicks off with a common resolution: quitting smoking.
Researchers at the Scripps Institute in La Jolla, California are working on a nicotine vaccine that could put an end to the addiction. Kim Janda, Ph.D.'s approach is to get the body's immune system to treat nicotine like a foreign invader.
But getting the body to respond in the right way is a big challenge, and lead to the failure of an earlier attempt at a vaccine by other researchers.
Janda wants his research to help change the perception of addiction from a moral failure of the individual to a scientific challenge of treating a brain disease.
Published in the Journal of Medicinal Chemistry: http://pubs.acs.org/doi/abs...
Find more publications at http://pubs.acs.org